Beijing Suncadia Pharmaceuticals Co., Ltd
Registry sponsor category
Industry
- Other names
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Company name
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (24)
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
- A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
- A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects
- A Single Ascending Dose of HRS-4029 in Healthy Subjects
- A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
- A Study of SHR-1918 In Participants With Hypertriglyceridemia
- A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
- A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
- A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction
- A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
- A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
- Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
- Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
- Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
- Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
- Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors
- Safety and Tolerability of SHR-1918 in Healthy Subjects
- Safety, Tolerability and Pharmacokinetic Study of HRS-8829
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects
- SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty